Biotech & Health Tech
Third Rock enters $2B partnership with AI-focused Chinese biotech
Third Rock Ventures is betting up to $2.16 billion on a little-known Chinese biotech’s AI platform. Funnel Biosciences describes itself as an AI-driven biologics company. Under a research collaboration announced Friday ...
Third Rock Ventures is betting up to $2.16 billion on a little-known Chinese biotech’s AI platform. Funnel Biosciences describes itself as an AI-driven biologics company. Under a research collaboration announced Friday ...
This is a summary of the story. Read the full article at Endpoints News (Biopharma) ↗